Sinco Pharms Hldg Ltd

Sinco Pharmaceuticals Holdings Limited is an investment holding company that provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. It offers human albumin serum under the Octapharma, Octapamma, and Octenor names for treating premature infants, hypovolemia, hypoproteinemia, neonatal hyperbilirubinemia, acute respiratory distress syndrome, cardiopulmonary bypass, special types of hemodialysis, and plasma exchange. It also provides Axetine for treating bacterial infections, including respiratory, urinary tract, soft tissue, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for preventing post-surgery infections. Additionally, the company engages in research, development, and sale of pharmaceutical products; provision of warehouse facilities; research and manufacturing of aesthetic medicine; international trade; consultation services for medical and biological technology; market promotion; and medical beauty services. Founded in 2011 and headquartered in Chengdu, the People's Republic of China, it operates as a subsidiary of Risun Investments Limited.